
A patient handed me his phone during a consultation. He wanted my opinion on a new treatment he’d found.
His erections were becoming less reliable. He had searched online and found what read like a doctor explaining why conventional treatment wasn’t addressing the underlying problem.
I started reading.
The advert told a compelling story: a cardiologist developing erectile dysfunction, discovering what was happening to his circulation and finding a treatment that conventional medicine had apparently overlooked.
There were artery diagrams. References to published research. A detailed biological explanation. Professional authority, reinforced by the vulnerability of a doctor describing his own illness.
Then I reached the explanation of how sildenafil works.
That was wrong.
My medical “spidey sense” was already twitching. But recognising one error didn’t tell me whether the other claims were supported. I had to open PubMed, check the citations and revisit pathways I hadn’t thought about properly for years.
The story interested me enough to make me do the work.
An intelligent person without medical training could find it thoroughly convincing. That deserves more attention than another lecture about patients believing things they read online.
First, give the reader a reason to worry
“The canary dies first.”
That was the advert’s framing for erectile dysfunction: smaller arteries revealing trouble before larger ones.
There is real medicine behind this. Erectile dysfunction can be associated with cardiovascular disease, and suspected vascular ED warrants cardiovascular risk assessment. The Princeton IV consensus explicitly addresses that relationship. [1]
It does not follow that every man with less reliable erections has obstructed arteries. But the genuine association gives the story a credible opening.
For someone already worried about sexual function, the stakes have now expanded to a possible heart attack. The advert offers to explain both.
This is where sophisticated medical misinformation earns its first foothold. It begins with something true, then asks the evidence to travel much further than it can.
Give the story references
One claim invoked research by Thompson and colleagues to suggest cardiovascular risk could be increased by up to 50-fold.
The actual paper reported a hazard ratio of 1.45 for subsequent cardiovascular events among men with prevalent or incident erectile dysfunction. It was published in JAMA, rather than the journal named in the advert. [2]
Those are substantial discrepancies.
The reference performs two jobs. It gives the claim an academic appearance, and it reassures a conscientious reader that there is something they could check.
But a paper can exist without supporting the sentence attached to it.
Citation laundering describes this borrowing of scientific authority: legitimate research is attached to a claim that exceeds, distorts or misrepresents its findings.
Spotting it takes more than checking whether the authors and title are real. You have to compare what the study actually measured with what the advert says it established.
Alter the biology to make room for the treatment
The advert’s explanation of sildenafil was where I first recognised a definite fault.
In the relevant pathway, nitric oxide stimulates the production of cyclic GMP, which helps smooth muscle relax. PDE5 breaks down cyclic GMP. Sildenafil inhibits PDE5, slowing that breakdown. [3]
PDE5 does not break down nitric oxide.
To many readers, that will sound like a technical distinction. Within the sales argument, however, an altered pathway can make an established treatment appear to act at the wrong point and a proposed alternative appear to address the underlying cause.
The biology is doing persuasive work.
Once the reader accepts the rewritten pathway, the next treatment can seem to follow logically from it. The missing evidence becomes harder to notice because the explanation feels complete.
Introduce some genuinely interesting research
The advert then turned to capsaicin, the compound responsible for the heat of chilli peppers, and its receptor, TRPV1.
This is a legitimate area of research. A 2010 paper in Cell Metabolism investigated capsaicin/TRPV1 signalling, endothelial function and vascular relaxation, including experiments in hypertensive rats. [4]
I can see why someone would find it interesting. I did.
But moving from those experiments to a supplement treating erectile dysfunction or reversing human coronary disease requires further evidence.
Does the preparation deliver an effective exposure? Does the relevant response occur in humans at a tolerable dose? Does it improve the outcome being promised?
Mechanistic inflation occurs when evidence about how something might work is presented as evidence that a treatment does work.
A receptor becomes a pathway. A pathway becomes a therapeutic effect. By the time a product appears, the reader has been carried across several unanswered questions.
We should be able to be excited by an emerging mechanism without pretending it has already become a treatment.
Nor does every worthwhile clinical inference require a large randomised trial. Mechanistic experiments, observational evidence and carefully documented clinical experience all contribute to medical knowledge. Their usefulness depends on the question, the quality of the observations and the alternative explanations.
The obligation is to show the reader where those observations end and the inference begins.
Supply the miracle
The story then offered a coronary calcium score falling from 47 to 31 in eight weeks.
A 34% reduction.
The arithmetic is correct. The interpretation requires considerably more work.
A coronary calcium score measures calcification; it is not a direct measurement of total plaque burden. Two reported scores, without the scans, acquisition details or an adequate account of what else changed, cannot establish that a supplement reversed coronary disease.
The relationship between calcification and treatment benefit is also more complicated than “less calcium means healing”. Research on statins has found increased plaque calcification alongside atheroma regression. [5]
Yet within the advert, the numbers arrive after the biological explanation. The reader has already been given a reason to expect recovery.
The testimonial then appears to confirm the mechanism.
That is a powerful sequence: worry, explanation, discovery, recovery.
Eventually, a product appears.
By then, buying it can feel like following the science.
Why a careful reader could believe it
What stayed with me was how much knowledge and checking it took to pull the argument apart.
The advert offered an explanation for something that worried my patient. Its references made it look checkable. Its biology made it feel coherent. The doctor’s personal story offered hope.
It reads like a medical consultation just for you.
It is also direct-response copywriting wearing a white coat.
The patient had done something sensible: taken an interest in his health and brought a proposed treatment to his doctor for discussion.
Dismissing that as gullibility would miss what happened.
A reader can be attentive, intelligent and willing to learn, yet still lack the specialist knowledge needed to recognise that a pathway has been altered or an animal experiment has become a promise of human recovery.
I knew enough to spot a fault. Even then, I had to do the work.
How much of that could we reasonably expect a patient to do?
Five questions before you trust the claim
You do not need to reconstruct every signalling pathway. Start by checking whether the evidence and the promise describe the same thing.
1. What was actually tested? The product being sold, one of its ingredients, or a biological mechanism?
2. In whom? People with the relevant condition, healthy volunteers, animals or cells?
3. What actually improved? Symptoms, clinical outcomes, a laboratory measurement or somebody’s personal account?
4. Does the reference support this particular claim? Check the size of the effect and the timescale. A related paper is insufficient.
5. Where does the certainty come from? The research itself, or the confidence and coherence of the story built around it?
If a product is revealed after a long scientific explanation, go back and examine the steps that led you there. Which were demonstrated? Which were proposed? Which were simply asserted?
You do not need to prove that a treatment can never work to recognise that an advert has failed to establish that it does.
References do not make a claim scientific. The relationship between the reference and the claim does.
References
[1] Kloner RA et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. Journal of Sexual Medicine. 2024;21(2):90–116. PubMed
[2] Thompson IM et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002. Paper
[3] Pfizer. Viagra prescribing information, section 12.1: Mechanism of Action. Prescribing information
[4] Yang D et al. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metabolism. 2010;12(2):130–141. PubMed
[5] Puri R et al. Impact of statins on serial coronary calcification during atheroma progression and regression. Journal of the American College of Cardiology. 2015;65(13):1273–1282. PubMed

